Philip A. DeSimone, MD

Clinical interests

  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Hematology
  • Medical Oncology

Philip A. DeSimone, MD


My name is Philip DeSimone; I received my medical degree from the University of Vermont, College of Medicine, Burlington. I completed a fellowship in Medical Oncology and Hematology at the University of Kentucky, Lexington.

I am board certified by the American Board of Internal Medicine in Hematology.

Read more of Teresa's story »

Faculty rank

Professor of Medicine


University of Vermont, College of Medicine, Burlington

University of Kentucky, Lexington

Medical Oncology and Hematology, University of Kentucky, Lexington

Certifications or Special training
American Board of Internal Medicine
American Board of Internal Medicine, Hematology

Gastrointestinal Cancer

Multidisciplinary Clinic

Markey Cancer Center
Whitney-Hendrickson Building
First Floor
800 Rose St.
Lexington KY 40536-0098

This is a clinic of the University of Kentucky Hospital, also known as UK Albert B. Chandler Hospital. Read more »

Medical Oncology

Multidisciplinary Clinic

Markey Cancer Center
Whitney-Hendrickson Building
First Floor, Room 134
800 Rose St.
Lexington KY 40536-0098

Call 859-323-5275
Call 859-323-8043
Fax 859-257-3757

Directions to Markey Cancer Center - Whitney-Hendrickson Building »

Medical Oncology

Harrison Memorial Hospital
1210 KY Highway 36 E.
Cynthiana KY 41031

UK HealthCare accepts many forms of insurance. See list of insurers »

  1. Arnold SM, Rinehart JJ, Tsakalozou E, Eckardt JR, Fields SZ, Shelton BJ, DeSimone PA, Kee BK, Moscow JA, Leggas M.
    A phase I study of 7-t-butyldimethylsilyl-10-hydroxycamptothecin in adult patients with refractory or metastatic solid malignancies.
    Clin Cancer Res. 2010 Jan 15;16(2):673-80.
  2. Bence AK, Anderson EB, Halepota MA, Doukas MA, DeSimone PA, Davis GA, Smith DA, Koch KM, Stead AG, Mangum S, Bowen CJ, Spector NL, Hsieh S, Adams VR.
    Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects.
    Invest New Drugs. 2005 Jan;23(1):39-49.
  3. Thompson JS, Haist SA, DeSimone PA, Engelberg J, Rich EC.
    The accelerated internal medicine program at the University of Kentucky.
    Ann Intern Med. 1992 Jun 15;116(12 Pt 2):1084-7.

A Patient's story - Surviving Organ Failure, Transplant & Cancer

Teresa Schladt’s life-size selfportrait, painted in 2013 during an art therapy project for organ transplant patients at UK Chandler Hospital, shows the Lexington woman springing into a star-filled, midnight-blue sky. Inside each star is the name of someone who supported her through her 2007 liver transplant and cancer treatment and in the days since. There are many, many stars and many, many names, among them family, friends and more than a few UK HealthCare medical professionals.

As the 55-year-old looks at the painting and considers the life she has, she is quick to remind others and herself, “I am one of the luckiest people you have ever met. I am happy with life.”

Read more of Teresa's story »